GlassScriptPhysician profile
Michael A Gasman
NPI 1851461248
$5,441.98
in general payments reported to CMS, 2019-2025
22 companies · $918 in 2025
The $918 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $687 · 2020: $1,199 · 2021: $575 · 2022: $539 · 2023: $857 · 2024: $667 · 2025: $918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,441.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,326.07 | 2019-2025 | Proclaim |
| Boston Scientific Corporation | $377.79 | 2020-2025 | Wavewriter Alpha Prime 16, Fixate |
| Zynex Medical, INC. | $341.52 | 2025 | Nexwave |
| Abbvie INC. | $224.07 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $205.91 | 2020-2024 | Xtampza |
| Relievant Medsystems, INC. | $196.91 | 2023 | Intracept |
| Nalu Medical, INC. | $168.36 | 2024 | Nalu Neurostimulation System |
| Teva Pharmaceuticals USA, INC. | $74.85 | 2019-2020 | |
| Daiichi Sankyo INC. | $66.94 | 2019 | |
| Saluda Medical Americas, INC. | $62.96 | 2023 | Evoke Scs |
| Lilly USA, LLC | $58.69 | 2019-2020 | |
| Painteq LLC | $54.51 | 2021 | |
| Pfizer INC. | $53.89 | 2019-2021 | |
| Almatica Pharma LLC | $38.69 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $35.46 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $30.79 | 2019-2020 | |
| Masimo Corporation | $27.95 | 2022 | |
| Electronic Waveform Lab, INC. | $22.70 | 2021 | |
| Amgen INC. | $20.85 | 2019 | |
| Saol Therapeutics INC. | $19.07 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.18 | 2025 | |
| Novartis Pharmaceuticals Corporation | $15.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gasman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.